Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |